MEI Pharma Future Growth

How is MEI Pharma forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


8.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqCM:MEIP - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202516-107-130-1304
6/30/20247-119-121-1215
6/30/202324-91-107-1075
9/30/202242-54-56-56N/A
6/30/202241-54-49-49N/A
3/31/202237-47-36-36N/A
12/31/202135-64-35-35N/A
9/30/202136-60-35-35N/A
6/30/202135-41-33-32N/A
3/31/202152-534848N/A
12/31/202045-315254N/A
9/30/202033-434243N/A
6/30/202028-473334N/A
3/31/20205-24-44-43N/A
12/31/20195-38-44-44N/A
9/30/20196-5-31-31N/A
6/30/20195-17-30-29N/A
3/31/20194-39-25-25N/A
12/31/20184-28-20-20N/A
9/30/20182-46-27-27N/A
6/30/20182-40-21-21N/A
3/31/20182-25-21-21N/A
12/31/20176-20-13-13N/A
9/30/201722-2-12-12N/A
6/30/201723333N/A
3/31/201723133N/A
12/31/201618-4-3-3N/A
9/30/20161-21-3-3N/A
6/30/2016N/A-21N/A-18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MEIP is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MEIP is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MEIP is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: MEIP's revenue (45.7% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: MEIP's revenue (45.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MEIP's Return on Equity is forecast to be high in 3 years time


Discover growth companies